High Risk Prostate Cancer Prevention Study
NCT01174953
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
finasteride
Sponsor
University of Kansas